In the only study to date examining adipose tissue in the context of NEC, Mimatsu et al. demonstrated that differentiated adipocytes, and not ADSCs, improved mortality and promoted intestinal healing in NEC by modulating fatty acid-related proteins and reducing inflammation, including IL-1 and IL-6 levels [45]. This evidence concerns the gene IL1A and necrotizing enterocolitis.